Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BYInternational journal of molecular sciences

Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.

  • Tülay Koç1
  • Sedanur Aydın2
  • Zeynep Öztürk1
  • Hatice Terzi3
  1. 1Department of Pathology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye.
  2. 2Department of Pathology, Sivas Numune Hospital, Sivas 58140, Türkiye.
  3. 3Department of Hematology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye.
Read full textPDFDOICite

Abstract

Follicular lymphoma (FL) is an indolent B-cell lymphoma with considerable biological and clinical heterogeneity, highlighting the need for additional prognostic biomarkers beyond conventional clinicopathological parameters. This study aimed to evaluate the prognostic significance of an immunohistochemical classification separating FL into a germinal center-like (GC-like) phenotype, characterized by retention of germinal-center-associated features, and a memory-like (Mem-like) phenotype, reflecting a more differentiated post-germinal-center/memory B-cell state. Fifty-one patients with FL were retrospectively analyzed for clinicopathological characteristics, immunohistochemical findings, relapse, and overall survival (OS). LMO2 expression was detected in 70.6% of cases and was associated with lower mortality (19.4% vs. 60.0%, p = 0.008), lower relapse rates (8.3% vs. 33.3%, p = 0.039), and improved 5-year OS (85.3% vs. 35.0%, log-rank p = 0.003). FOXP1 positivity was observed in 41.2% of cases and was associated with higher mortality (57.1% vs. 13.3%, p = 0.002) and inferior 5-year OS (44.5% vs. 89.4%, log-rank p < 0.001). Mem-like patients had significantly poorer 5-year OS than GC-like patients (39.5% vs. 90.1%, log-rank p < 0.001). These findings suggest that LMO2 and FOXP1 expression may provide complementary prognostic information and help identify clinically distinct immunophenotypic subsets in FL.

Related

  1. Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
    Juan Ramón Berenguer-Marí, Luis Álvarez, Julia Sierra-Roca +8
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Prognostic Significance of the ESTRO/EORTC Classification of Oligometastatic Disease for Colorectal Cancer Patients With Uncommon Metastases Treated With Definitive Radiotherapy
    TAO-WEI KE, WILLIAM TZU-LIANG CHEN, SHENG-CHI CHANG +9
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. Prognostic significance and clinicopathologic prediction of tumor deposits in non-metastatic colon mucinous adenocarcinoma
    Yidan Qu, Jizheng Gong, Wenwei Lan +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  4. Prognostic Significance of Serum Sodium in Patients With Acute Pulmonary Embolism
    Patchara Kochaiyapatana, Sukrisd Koowattanatianchai, Jayanton Patumanond +2
    Journal of Clinical Medicine ResearchPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer
    Sendag Yaslikaya, Suheda Atas Ipek, Tugba Toyran +2
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{koc2026immunohistochemical,
  title = {{Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.}},
  author = {Tülay Koç and Sedanur Aydın and Zeynep Öztürk and Hatice Terzi},
  journal = {International journal of molecular sciences},
  year = {2026},
  month = sep,
  doi = {10.3390/ijms27198611},
  url = {https://europepmc.org/article/MED/42883858},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.
AU  - Tülay Koç
AU  - Sedanur Aydın
AU  - Zeynep Öztürk
AU  - Hatice Terzi
PY  - 2026
DA  - 2026/09/26
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27198611
UR  - https://europepmc.org/article/MED/42883858
AB  - Follicular lymphoma (FL) is an indolent B-cell lymphoma with considerable biological and clinical heterogeneity, highlighting the need for additional prognostic biomarkers beyond conventional clinicopathological parameters. This study aimed to evaluate the prognostic significance of an immunohistochemical classification separating FL into a germinal center-like (GC-like) phenotype, characterized by retention of germinal-center-associated features, and a memory-like (Mem-like) phenotype, reflecting a more differentiated post-germinal-center/memory B-cell state. Fifty-one patients with FL were retrospectively analyzed for clinicopathological characteristics, immunohistochemical findings, relapse, and overall survival (OS). LMO2 expression was detected in 70.6% of cases and was associated with lower mortality (19.4% vs. 60.0%, p = 0.008), lower relapse rates (8.3% vs. 33.3%, p = 0.039), and improved 5-year OS (85.3% vs. 35.0%, log-rank p = 0.003). FOXP1 positivity was observed in 41.2% of cases and was associated with higher mortality (57.1% vs. 13.3%, p = 0.002) and inferior 5-year OS (44.5% vs. 89.4%, log-rank p < 0.001). Mem-like patients had significantly poorer 5-year OS than GC-like patients (39.5% vs. 90.1%, log-rank p < 0.001). These findings suggest that LMO2 and FOXP1 expression may provide complementary prognostic information and help identify clinically distinct immunophenotypic subsets in FL.
SN  - 1422-0067
ER  -